Scientists make DNA discovery that could help find pancreatic cancer cure
Scientists discover pancreatic cancer deactivates crucial genes, aiding rapid growth. Study reveals DNA methylation silences HNF4A gene, essential for organ function. Research offers hope for new treatments, funded by Pancreatic Cancer UK.
Read original article
Scientists have made a significant DNA discovery related to pancreatic cancer, a disease with one of the worst survival rates among common cancers. Researchers from the UK and US found that pancreatic cancer can deactivate molecules in crucial genes, aiding the rapid growth and spread of the disease. Pancreatic cancer is diagnosed in over half a million people annually and has poor survival rates. The discovery offers hope for new treatments by shedding light on how the cancer behaves and spreads. The study revealed that pancreatic cancer triggers DNA methylation, silencing molecules in the HNF4A gene, which is essential for organ function. This finding could lead to potential new treatments in the future. Pancreatic cancer is often diagnosed late, limiting treatment options and resulting in a high mortality rate. The research, funded by Pancreatic Cancer UK, aims to improve understanding of the disease's aggressiveness to develop more effective treatments.
Related
Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells
Researchers at Penn State University developed a genetic circuit to re-engineer cancerous tumors, causing self-destruction and targeting drug-resistant cells. Published in Nature Biotechnology, the study shows promising results in combating cancer evolution and drug resistance.
Scientists create a cell that precludes malignant growth
Scientists at the University of Helsinki developed a cell preventing malignant growth, enhancing therapies for diseases like diabetes. Engineered cells show promise in regulating glucose levels and evading immune rejection, advancing safer cell therapies.
Scientists Discover a Cause of Lupus, Possible Way to Reverse It
Scientists discovered a molecular defect in lupus, aiming to reverse it to potentially cure the disease affecting 1.5 million Americans. Targeting immune imbalance could lead to safer and more effective treatments.
Charm creates a potent therapy candidate for fatal prion diseases
A collaboration between Broad Institute and Whitehead Institute developed CHARM, a gene-silencing tool for prion diseases. CHARMs target disease-causing genes through epigenetic editing, showing promise in mice with low toxicity. Researchers aim to optimize CHARMs for clinical trials.
Nanorobot with hidden weapon kills cancer cells
Researchers at Karolinska Institutet developed nanorobots targeting cancer cells in mice. The nanorobots use a hidden weapon activated in acidic tumor environments, reducing tumor growth by 70% in tests. Further research is needed for human trials.
2 commentsSteve had an islet cell neuroendocrine cancer which is much more rare.
Related
Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells
Researchers at Penn State University developed a genetic circuit to re-engineer cancerous tumors, causing self-destruction and targeting drug-resistant cells. Published in Nature Biotechnology, the study shows promising results in combating cancer evolution and drug resistance.
Scientists create a cell that precludes malignant growth
Scientists at the University of Helsinki developed a cell preventing malignant growth, enhancing therapies for diseases like diabetes. Engineered cells show promise in regulating glucose levels and evading immune rejection, advancing safer cell therapies.
Scientists Discover a Cause of Lupus, Possible Way to Reverse It
Scientists discovered a molecular defect in lupus, aiming to reverse it to potentially cure the disease affecting 1.5 million Americans. Targeting immune imbalance could lead to safer and more effective treatments.
Charm creates a potent therapy candidate for fatal prion diseases
A collaboration between Broad Institute and Whitehead Institute developed CHARM, a gene-silencing tool for prion diseases. CHARMs target disease-causing genes through epigenetic editing, showing promise in mice with low toxicity. Researchers aim to optimize CHARMs for clinical trials.
Nanorobot with hidden weapon kills cancer cells
Researchers at Karolinska Institutet developed nanorobots targeting cancer cells in mice. The nanorobots use a hidden weapon activated in acidic tumor environments, reducing tumor growth by 70% in tests. Further research is needed for human trials.